AzTrials
AzTrials

Weakness, MuscleSTILLNCT05072652

Short Term Immobilization of the Lower Limb

A study testing Neuromuscular Electrical Stimulation and Action Observation + Mental Imagery in people with Weakness, Muscle and Muscle Weakness, run by University of Central Florida at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study is to determine the effects of one week of knee-joint immobilization on muscle size, strength, neuromuscular function, and brain function. In addition, the effects of two different interventions (i.e., neuromuscular electrical stimulation and action observation/mental imagery) throughout… Read more about this study

Who is it for?
Ages 18 to 40 yearsHealthy volunteers can take part
Conditions the study is for
Weakness, Muscle, Muscle Weakness, Muscle Loss
What is being tested?
Neuromuscular Electrical Stimulation and Action Observation + Mental Imagery
Could I receive a placebo?
No, everyone receives an active treatment
How many people
50 participants
Where
1 siteUnited States
Study dates
11 Oct 2021to 1 Jul 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 40 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Healthy men and women between the ages of 18-40 years
  • Body mass index >20 kg/m2 or < 35 kg/m2

Who cannot join

  • Body mass index <20 kg/m2 or > 35 c
  • Experience of major joint pain/discomfort of the upper or lower limbs, back, or neck within the previous six months.
  • History of major musculoskeletal injury or surgery
  • Neuromuscular disease (e.g., Parkinson's, MS, ALS)
  • Metabolic disease (e.g., diabetes, thyroid disorder, metabolic syndrome)
  • Personal or family history of blood clots
Show all 23Show fewer
  • Trouble using or controlling one's muscles
  • History of cancer
  • History of stroke
  • History of heart attack
  • History of arthritis
  • Use of an assistive walking device or mobility aids within the past six months
  • Use of anabolic steroids within the past six months
  • History of convulsions, seizures, or syncope
  • History of concussion as diagnosed by a physician
  • Certain medications (e.g., muscle relaxants, benzodiazepines)
  • Very thick hair or certain hairstyles that would impede the TMS coil from making direct contact with the scalp
  • Allergy to rubbing alcohol
  • Lack of transportation to and from the laboratory
  • Implant of any kind
  • Pregnancy
  • Allergy to silver
  • Diagnosis of any psychiatric condition

Trial locations and contacts

1 site in 1 country.

United States1 site
  • University of Central Florida

    Orlando, Florida, 32816

Other trials in United States

About this study

Official title: Short-term Immobilization and Rehabilitation of the Lower Limb: Changes in Strength, Size, and Neuromuscular Function

The purpose of this study is to determine the effects of one week of knee-joint immobilization on muscle size, strength, neuromuscular function, and brain function. In addition, the effects of two different interventions (i.e., neuromuscular electrical stimulation and action observation/mental imagery) throughout immobilization will be determined. Following the immobilization period, participants that have lost strength will be rehabilitated with twice weekly resistance training sessions, and sex-based differences in rehabilitation timelines will be examined.

Read the detailed description

This study will utilize a repeated measures design in healthy adults aged 18-40 years. After a thorough familiarization visit, muscular size, strength, neuromuscular responses, and corticospinal excitability/inhibition will be measured before (PRE) and after (POST) one week of unilateral knee joint immobilization of the left leg. Four groups will be examined: 1) immobilization only, 2) immobilization + daily neuromuscular electrical stimulation, 3) immobilization + daily action observation/mental imagery training, 4) a control group. Throughout the immobilization period, participants will be in a leg brace locked at 90 degrees knee flexion. They will perform daily range of motion exercises and wear a compression sock at all times to mitigate the risk of blood clots. Following completion of the immobilization period, participants that have lost strength will complete a supervised rehabilitation program of twice weekly lower body resistance training sessions until they have returned to baseline levels of strength. Group assignment will be randomized and blocked on sex to ensure an equal number of participants within each group consisting of a relatively equal number of males and females.

Being tested
Neuromuscular Electrical Stimulation, Action Observation + Mental Imagery
Keywords
immobilization, muscle atrophy, muscle strength, action observation, mental imagery, neuromuscular electrical stimulation, rehabilitation
Medical subject headings
Muscle Weakness, Muscular Atrophy, Knee Injuries

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Neuromuscular Electrical StimulationOther

    Participants in this group will perform twice daily neuromuscular electrical stimulation training sessions of the quadriceps muscles (specifically, the vastus lateralis and rectus femoris) or the immobilized left leg.

  • Action Observation + Mental ImageryOther

    Participants in this group will perform daily action observation + mental imagery training via video and audio recordings.

Study groups in NCT05072652
Study groupRoleWhat they receive
ImmobilizationExperimentalParticipants in the immobilization groups will undergo one week of unilateral knee joint immobilization of the left leg.
Receives: Other: Neuromuscular Electrical Stimulation; Other: Action Observation + Mental Imagery
ControlNo interventionThe control group will not undergo any intervention.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Muscular strength

    Changes in muscular strength will be measured via maximal voluntary contraction torque

    Measured: 15 minutes

  2. Muscular size

    Changes in muscular size will be measured via ultrasonography of the quadriceps

    Measured: 10 minutes

  3. Corticospinal responses

    Corticospinal responses will be measured with transcranial magnetic stimulation targeting the lower limbs

    Measured: 30 minutes

  4. Motor unit behavior

    Motor unit recruitment threshold and firing rate will be measured with surface electromyography signals detected from the quadriceps

    Measured: 10 minutes

  5. Voluntary activation

    Voluntary activation will be measured using the interpolated twitch technique

    Measured: 15 minutes

  6. Rate of recovery

    The time taken to recover strength lost will be measured via number of resistance training sessions needed after immobilization

    Measured: 1.5 hours per session

Secondary outcomes (2)
  1. Compliance

    Compliance will be measured via the use of accelerometers around both ankles. Compliance will be calculated as the number of participants that following the crutch/brace protocol as described.

    Measured: one week

  2. Physical activity (Step count)

    Physical activity will be assessed via step counts and compared to changes in primary outcome measures via accelerometers around both ankles

    Measured: one week

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 Oct 2021
  2. Study start11 Oct 2021
  3. Primary completion1 Jun 2022
  4. Study completion1 Jul 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Model description
Repeated measures design
Masking
None (open label)
Enrolment
50 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05072652
Sponsor's protocol ID
00003289
Acronym
STILL
Status last verified
Aug 2022
First submitted
28 Sep 2021
Last updated
19 Aug 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: IPD will be shared by the PI upon reasonable request. Personal identifiable information will not be shared; however, physiological data and outcome measures may be shared if requested.

Publications

  • Harmon KK, Girts RM, Rodriguez G, Beausejour JP, Pagan JI, Carr JC, Garcia J, Roberts MD, Hahs-Vaughn DL, Stout JR, Fukuda DH, Stock MS. Combined action observation and mental imagery versus neuromuscular electrical stimulation as novel therapeutics during short-term knee immobilization. Exp Physiol. 2024 Jul;109(7):1145-1162. doi: 10.1113/EP091827. Epub 2024 Apr 30.

    PubMed 38687158

Questions about this trial

What is this clinical trial studying?

A study testing Neuromuscular Electrical Stimulation and Action Observation + Mental Imagery in people with Weakness, Muscle and Muscle Weakness, run by University of Central Florida at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 23 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 19 Aug 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Muscular strength (time frame: 15 minutes). The study lists 6 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05072652, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Aug 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in